|
|
(2 intermediate revisions not shown.) |
Line 1: |
Line 1: |
| | | |
| ==APO-CELLULAR RETINOIC ACID BINDING PROTEIN II== | | ==APO-CELLULAR RETINOIC ACID BINDING PROTEIN II== |
- | <StructureSection load='1xca' size='340' side='right' caption='[[1xca]], [[Resolution|resolution]] 2.30Å' scene=''> | + | <StructureSection load='1xca' size='340' side='right'caption='[[1xca]], [[Resolution|resolution]] 2.30Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[1xca]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XCA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1XCA FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[1xca]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XCA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1XCA FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1xca FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1xca OCA], [http://pdbe.org/1xca PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1xca RCSB], [http://www.ebi.ac.uk/pdbsum/1xca PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1xca ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1xca FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1xca OCA], [https://pdbe.org/1xca PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1xca RCSB], [https://www.ebi.ac.uk/pdbsum/1xca PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1xca ProSAT]</span></td></tr> |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[http://www.uniprot.org/uniprot/RABP2_HUMAN RABP2_HUMAN]] Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors. | + | [https://www.uniprot.org/uniprot/RABP2_HUMAN RABP2_HUMAN] Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors. |
| == Evolutionary Conservation == | | == Evolutionary Conservation == |
| [[Image:Consurf_key_small.gif|200px|right]] | | [[Image:Consurf_key_small.gif|200px|right]] |
Line 29: |
Line 30: |
| | | |
| ==See Also== | | ==See Also== |
- | *[[Cellular retinoic acid-binding protein|Cellular retinoic acid-binding protein]] | + | *[[Cellular retinoic acid-binding protein 3D structures|Cellular retinoic acid-binding protein 3D structures]] |
| == References == | | == References == |
| <references/> | | <references/> |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
- | [[Category: Chen, X]] | + | [[Category: Large Structures]] |
- | [[Category: Ji, X]] | + | [[Category: Chen X]] |
- | [[Category: Crabpii]] | + | [[Category: Ji X]] |
- | [[Category: Ligand entry]]
| + | |
- | [[Category: Retinoic acid]]
| + | |
- | [[Category: Retinoic acid transport]]
| + | |
- | [[Category: Vitamin some]]
| + | |
| Structural highlights
Function
RABP2_HUMAN Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors.
Evolutionary Conservation
Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.
Publication Abstract from PubMed
The crystal structure of unliganded mutant R111M of human cellular retinoic acid-binding protein type II (apo-CRABPII (R111M)) has been determined at 2.3 A and refined to a crystallographic R-factor of 0. 18. Although the mutant protein has lower affinity for all-trans-retinoic acid (RA) than the wild-type, it is properly folded, and its conformation is very similar to the wild-type. apo-CRABPII (R111M) crystallizes in space group P1 with two molecules in the unit cell. The two molecules have high structural similarity except that their alpha2 helices differ strikingly. Analyses of the molecular conformation and crystal packing environment suggest that one of the two molecules assumes a conformation compatible with RA entry. Three structural elements encompassing the opening of the binding pocket exhibit large conformational changes, when compared with holo-CRABPII, which include the alpha2 helix and the betaC-betaD and betaE-betaF hairpin loops. The alpha2 helix is unwound at its N terminus, which appears to be essential for the opening of the RA-binding pocket. Three arginine side-chains (29, 59, and 132) are found with their guanidino groups pointing into the RA-binding pocket. A three-step mechanism of RA entry has been proposed, addressing the opening of the RA entrance, the electrostatic potential that directs entry of RA into the binding pocket, and the intramolecular interactions that stabilize the RA.CRABPII complex via locking the three flexible structural elements when RA is bound.
Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry.,Chen X, Tordova M, Gilliland GL, Wang L, Li Y, Yan H, Ji X J Mol Biol. 1998 May 8;278(3):641-53. PMID:9600845[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Chen X, Tordova M, Gilliland GL, Wang L, Li Y, Yan H, Ji X. Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry. J Mol Biol. 1998 May 8;278(3):641-53. PMID:9600845 doi:http://dx.doi.org/10.1006/jmbi.1998.1734
|